Hannah Joseph Hospital IPO Date, Price, Allotment Details

Hannah Joseph Hospital IPO open date is January 22, 2026 and the IPO will close on January 27, 2026. Hannah Joseph Hospital IPO is a Book building IPO Issue. The company to raise around ₹42 crores via IPO that comprises fresh issue of ₹42.00 crores and offer for sale up to [.] equity shares with face value of ₹10 each.

Hannah Joseph Hospital IPO price band is ₹67 to ₹70 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Hannah Joseph Hospital IPO to list on BSE SME on January 30, 2026. The allotment of Hannah Joseph Hospital IPO date is January 28, 2026.

The company reported revenue of ₹77.90 crores in 2025 against ₹63.63 crores in 2024. The company reported profit of ₹7.21 crores in 2025 against profit of ₹14.07 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.

About Hannah Joseph Hospital IPO

Hannah Joseph Hospital Limited, founded in 2011, is one of the growing medical and healthcare services provider in India. The company offers medical services across various departments, such as Neurology, Cardiology, Psychiatry, and Trauma healthcare. Hannah Joseph is a Multi-Specialty hospital situated in Madurai with a 2-acre campus. The business has a total of 364 employees as of 2025.

The healthcare hospital is equipped with central air-conditioning, a water heating system, and a combined capacity of 150 beds. Moreover, the company has been renowned for offering 24/7 Emergency care, 30+ world-class amenities, and 70+ specialized doctors to provide quality healthcare at affordable prices.

Incorporated in 2011, Hannah Joseph Hospital Limited is a multi-specialty healthcare provider offering quality medical services across key specialties.

Located in Madurai, the hospital operates on a 2-acre campus with central air-conditioning and water heating systems, providing a capacity of 150 beds.

Focuses on delivering quality and affordable healthcare, with strong emphasis on Neurology, Cardiology, Psychiatry, and Trauma Care.

Key departments include:

• Neurosciences – Neurology & Neurosurgery

• Cardio Sciences – Cardiology

• Trauma Care – Orthopaedics, Oral & Maxillofacial Surgery

• Psychiatry – Mental health services

As of November 30, 2025, the hospital employs 364 staff across medical, nursing, and support functions.

IPO proceeds will be utilised for establishing a Radiation Oncology Centre (₹34.98 cr) and general corporate purposes.

Strength

Strong expertise in neurosciences – Established reputation in neurology and neurosurgery services.

Advanced cardiac care capabilities – Well-developed cardiology services supporting critical care needs.

Specialised trauma and orthopaedic care – Integrated trauma management enhances emergency response and outcomes.

Weakness

Radiation oncology execution risk – Delays in equipment procurement, approvals, or commissioning may impact timelines and costs.

Regulatory approval dependency – Failure to obtain or renew statutory licenses for the oncology centre could affect operations.

Project implementation uncertainty – No assurance that the new centre will be completed within the planned schedule or budget.